| Details |
title |
year |
| Details |
PL03: PRESIDENTIAL SYMPOSIUM TUESDAY, DECEMBER 6, 2016 - 08:35-10:25 PL03... |
2016 |
| Details |
SESSION PL04A: IMMUNE CHECKPOINT INHIBITORS IN ADVANCED NSCLC WEDNESDAY, D... |
2016 |
| Details |
3RD-LINE LOCALLY ADVANCED OR METASTATIC, EGFR/ALK WILD-TYPE NSCLC: RESULTS... |
2016 |
| Details |
PL04: IMMUNE CHECKPOINT INHIBITORS IN ADVANCED NSCLC WEDNESDAY, DECEMBER ... |
2016 |
| Details |
PL03: PRESIDENTIAL SYMPOSIUM TUESDAY, DECEMBER 6, 2016 - 08:35-10:25 PL03... |
2016 |
| Details |
PL03: PRESIDENTIAL SYMPOSIUM TUESDAY, DECEMBER 6, 2016 - 08:35-10:25 PL03.... |
2016 |
| Details |
SC06: NOVEL THERAPIES IN MALIGNANT PLEURAL MESOTHELIOMA AND THYMIC MALIGNA... |
2016 |
| Details |
YI01A: CLINICAL TRIALS & SCIENTIFIC MENTORING SUNDAY, DECEMBER 04, 2016 - ... |
2016 |
| Details |
OA03: IMMUNOTHERAPY CHECKPOINT INHIBITORS IN ADVANCED NSCLC MONDAY, DECEMB... |
2016 |
| Details |
OA03: IMMUNOTHERAPY CHECKPOINT INHIBITORS IN ADVANCED NSCLC MONDAY, DECEMB... |
2016 |
| Details |
OA04: EPIDEMIOLOGY AND PREVENTION OF LUNG CANCER MONDAY, DECEMBER 5, 2016 ... |
2016 |
| Details |
OA05.01 PEMBROLIZUMAB IN PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CAN... |
2016 |
| Details |
OA13.01 A PHASE II STUDY OF NIVOLUMAB IN MALIGNANT PLEURAL MESOTHELIOMA (N... |
2016 |
| Details |
OA16: IMPROVING THE QUALITY OF LUNG CANCER CARE - PATIENTS PERSPECTIVE TUE... |
2016 |
| Details |
OA16: IMPROVING THE QUALITY OF LUNG CANCER CARE - PATIENTS PERSPECTIVE TUE... |
2016 |
| Details |
MA11: NOVEL APPROACHES IN SCLC AND NEUROENDOCRINE TUMORS TUESDAY, DECEMBER... |
2016 |
| Details |
POSTER SESSION 1 - P1.01: EPIDEMIOLOGY, TOBACCO CONTROL AND CESSATION/ PREV... |
2016 |
| Details |
POSTER SESSION 1 - P1.03: RADIOLOGY/STAGING/SCREENING STAGING MONDAY, DE... |
2016 |
| Details |
POSTER SESSION 1 - P1.06: ADVANCED NSCLC & CHEMOTHERAPY/TARGETED THERAPY/ I... |
2016 |
| Details |
POSTER SESSION 1 - P1.07: SCLC/NEUROENDOCRINE TUMORS DRUG TREATMENT ALONE ... |
2016 |